Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • after treatment (1)
  • diagnosis (1)
  • female (1)
  • homeostasis (2)
  • humans (1)
  • male (1)
  • mexidol (5)
  • nervous system (1)
  • patients (5)
  • picolines (2)
  • Sizes of these terms reflect their relevance to your search.

    To evaluate the efficacy of mexidol and necessity of using it in patients with endocrine polyneuropathies caused by primary hypothyroidism (PPHT). MATERIALS AND METHODS; We have examined 51 patients with confirmed diagnosis of PPHT and assessed their neurological status and indicators of metabolic homeostasis before and after treatment. Electroneuromyography (ENMG) was performed to assess the status of the peripheral nervous system. The results indicate the presence of endocrine disorders of obligate metabolic homeostasis in patients with polyneuropathies. Antioxidants, in particular, mexidol, in a complex with other drugs can be used in the treatment of these disorders. Worsening of ENMG-parameters, demonstrating a trend towards the normalization in response to treatment antioxidants, are characteristics of this pathology. The efficacy of mexidol in patients with PPHT has been confirmed.

    Citation

    E B Kuznetsova, I I Sholomov, S V Gerasimov, E A Salina. Efficiency of mexidol in patients with endocrine polyneuropathy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoĭ promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe obshchestvo nevrologov [i] Vserossiĭskoe obshchestvo psikhiatrov. 2014;114(4):97-9

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 24874328

    View Full Text